Exact Mass: 267.0793
Exact Mass Matches: 267.0793
Found 102 metabolites which its exact mass value is equals to given mass value 267.0793,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
S-Ribosylhomocysteine
S-(5-deoxy-beta-D-ribos-5-yl)-L-homocysteine is an S-(5-deoxy-D-ribos-5-yl)-L-homocysteine in which the anomeric centre has beta-configuration. It has a role as an Escherichia coli metabolite. It is functionally related to a L-homocysteine.
(S)-2-Amino-5-((4-nitrophenyl)amino)-5-oxopentanoic acid
3'-C-Ethynylcytidine
L-erythro-N-benzoyl-3-hydroxy-glutamic acid|L-erythro-N-Benzoyl-3-hydroxy-glutaminsaeure
N2-(4-Nitrophenyl)-L-glutamine
CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2776; ORIGINAL_PRECURSOR_SCAN_NO 2775 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2670; ORIGINAL_PRECURSOR_SCAN_NO 2668 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2770; ORIGINAL_PRECURSOR_SCAN_NO 2767 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2698; ORIGINAL_PRECURSOR_SCAN_NO 2695 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2719; ORIGINAL_PRECURSOR_SCAN_NO 2717 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2769; ORIGINAL_PRECURSOR_SCAN_NO 2768 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5877; ORIGINAL_PRECURSOR_SCAN_NO 5874 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5889; ORIGINAL_PRECURSOR_SCAN_NO 5886 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5895; ORIGINAL_PRECURSOR_SCAN_NO 5893 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5903; ORIGINAL_PRECURSOR_SCAN_NO 5901 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5926; ORIGINAL_PRECURSOR_SCAN_NO 5924 CONFIDENCE standard compound; INTERNAL_ID 389; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5926; ORIGINAL_PRECURSOR_SCAN_NO 5925
N-(2-Methylphenyl)-4-(3-pyridinyl)-1,3-thiazol-2-amine
2,5-DIMETHYL-1-(2-(TRIFLUOROMETHYL)PHENYL)-1H-PYRROLE-3-CARBALDEHYDE
5-Benzyl-4-phenyl-4H-1,2,4-triazol-3-ylhydrosulfide
4-(4-METHYLPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL
ethyl 5-amino-1-(2,5-difluorophenyl)pyrazole-4-carboxylate
4-METHOXY-2-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-AMINE
ethyl 5-amino-1-(2,4-difluorophenyl)pyrazole-4-carboxylate
2-[carboxymethyl(phenylmethoxycarbonyl)amino]acetic acid
(4-CHLORO-3-(PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID
3-CHLORO-4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID
(3-CHLORO-4-(CYCLOPENTYLCARBAMOYL)PHENYL)BORONIC ACID
(3-Chloro-5-(piperidine-1-carbonyl)phenyl)boronic acid
5-(4-Methyl-[1,1-biphenyl]-4-yl)-1,3,4-thiadiazol-2-amine
4-[(3,5-Dimethyl-4-isoxazolyl)methoxy]-2,6-difluorobenzenemethanol
3-amino-1-cyclopropyl-6,7-difluoro-8-methylquinazoline-2,4-dione
Propenidazole
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AF - Imidazole derivatives P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AB - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
4-(3,4-DIFLUOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID
Methyl 5-(2-(methylamino)phenyl)-1H-pyrazole-3-carboxylate hydrochloride
dimethyl 2-(4-methoxycarbonylpyridin-3-yl)propanedioate
4-(2,4-DIFLUOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID
3-(TRIFLUOROMETHYL)-N-(2,2-DIMETHOXYETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE
4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol
(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
2-(alpha-D-Mannopyranosylthio)ethanimidic acid methyl ester
ETHYL 4-CHLORO-5-ISOPROPYLPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBOXYLATE
3-C-Ethynylcytidine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Ethynylcytidine (ECyD), a nucleoside analog and a potent inhibitor of RNA synthesis, inhibits RNA polymerases I, II and II. Ethynylcytidine has robust antitumor activity in a wide range of models of cancer[1][2][3]. Ethynylcytidine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Benzyl alcohol, o-chloro-alpha-((isopropylamino)methyl)-, hydrochloride, monohydrate
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
4-hexyl-3-thiophen-2-yl-1H-1,2,4-triazole-5-thione
4-pyridin-4-yl-2-sulfanylidene-5,6,7,8-tetrahydro-1H-quinoline-3-carbonitrile
(S)-2-Amino-4-[(2S,3R)-2,3,5-trihydroxy-4-oxo-pentyl]mercapto-butyric acid
Methyl(2-acetoxy-2-(2-carboxy-4-amino-phenyl))acetate
3-deoxy-D-glycero-beta-D-galacto-nonulosonate
A carbohydrate acid derivative anion obtained by deprotonation of the carboxy group of 3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid
2-(alpha-D-mannosyl)-D-glycerate
Conjugate base of 2-(alpha-D-mannosyl)-D-glyceric acid
5-(4-Hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolane-3-carboxylate
4-butyl-3-(5-ethyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione
2-Methyl-5-(3-thiophenyl)-3,5-dihydropyrazolo[1,5-c]quinazoline
2-imino-2-methoxyethyl 1-thio-alpha-D-mannopyranoside
(2S)-2-[2-(pyridine-4-carbonyl)hydrazinyl]pentanedioic acid
7-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrrolo[2,3-d]pyrimidine-2,4-dione
S-(5-deoxy-beta-D-ribos-5-yl)-L-homocysteine
An S-(5-deoxy-D-ribos-5-yl)-L-homocysteine in which the anomeric centre has beta-configuration.
S-(5-deoxy-D-ribos-5-yl)-L-homocysteine zwitterion
Zwitterionic form of S-(5-deoxy-D-ribos-5-yl)-L-homocysteine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
(3r,6s,8s)-6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid
astone
{"Ingredient_id": "HBIN017208","Ingredient_name": "astone","Alias": "NA","Ingredient_formula": "C11H19Cl2NO2","Ingredient_Smile": "CC(C)NCC(C1=CC=CC=C1Cl)O.O.Cl","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30631","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
